Samsung Biologics Co.,Ltd. (KRX:207940)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,030,000
+13,000 (1.28%)
At close: Sep 5, 2025

Samsung Biologics Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202016 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2020
Net Income
1,285,9021,083,316857,691798,056393,589240,975
Upgrade
Depreciation & Amortization
649,237599,101489,782308,264161,789143,688
Upgrade
Loss (Gain) From Sale of Assets
2,0972,1993,8662,5887,4661,841
Upgrade
Asset Writedown & Restructuring Costs
70,28562,655--725.891,352
Upgrade
Loss (Gain) From Sale of Investments
-1,357-597.28-5,152-72,653-269.12-303.96
Upgrade
Loss (Gain) on Equity Investments
-18,376-2,660499.42-27,260-13,85317,768
Upgrade
Provision & Write-off of Bad Debts
-12,217-6,38021,51122,4074,857-
Upgrade
Other Operating Activities
-145,805-33,004-711.89185,130135,132304.75
Upgrade
Change in Accounts Receivable
128,439-450,99230,127-305,336-120,660-61,480
Upgrade
Change in Inventory
-343,503-236,200-273,896-179,912-370,571-184,885
Upgrade
Change in Accounts Payable
291,276409,295267,037134,59421,06058,253
Upgrade
Change in Unearned Revenue
35,96910.5827,19944,017--
Upgrade
Change in Other Net Operating Assets
394,364232,511248,27643,151235,330-15,422
Upgrade
Operating Cash Flow
2,336,3111,659,2551,666,229953,048454,596202,090
Upgrade
Operating Cash Flow Growth
41.29%-0.42%74.83%109.65%124.95%1890.33%
Upgrade
Capital Expenditures
-1,879,807-1,303,573-995,071-956,840-406,254-139,665
Upgrade
Sale of Property, Plant & Equipment
2,6141,3892,81164.0137.6447.69
Upgrade
Cash Acquisitions
--601,956-1,071,525-1,081,821--
Upgrade
Sale (Purchase) of Intangibles
-69,682-73,952-110,254-52,386-14,898-8,901
Upgrade
Investment in Securities
-355,320734,318607,760-1,015,673-512,375-270,167
Upgrade
Other Investing Activities
-0-0-0178.52-0-
Upgrade
Investing Cash Flow
-2,302,196-1,243,776-1,566,305-3,106,477-933,489-418,686
Upgrade
Short-Term Debt Issued
-237,000758,500593,75050,00030,000
Upgrade
Long-Term Debt Issued
-892,65945,000211,903648,356499,952
Upgrade
Total Debt Issued
1,094,6591,129,659803,500805,653698,356529,952
Upgrade
Short-Term Debt Repaid
--684,500-686,783-496,988-30,000-150,000
Upgrade
Long-Term Debt Repaid
--878,947-751,967-496,906-171,734-257,392
Upgrade
Total Debt Repaid
-1,366,106-1,563,447-1,438,750-993,894-201,734-407,392
Upgrade
Net Debt Issued (Repaid)
-271,447-433,788-635,250-188,241496,622122,560
Upgrade
Issuance of Common Stock
---3,200,751--
Upgrade
Other Financing Activities
--200-12,430-00
Upgrade
Financing Cash Flow
-271,447-433,788-635,0503,000,080496,622122,560
Upgrade
Foreign Exchange Rate Adjustments
-26,69841,59312,245-3,242831.1-2,215
Upgrade
Net Cash Flow
-264,03123,284-522,882843,40918,560-96,251
Upgrade
Free Cash Flow
456,504355,682671,158-3,79248,34362,425
Upgrade
Free Cash Flow Growth
-57.10%-47.01%---22.56%-
Upgrade
Free Cash Flow Margin
9.07%7.82%18.17%-0.13%3.08%5.36%
Upgrade
Free Cash Flow Per Share
6413.914997.369429.82-54.32730.64943.48
Upgrade
Cash Interest Paid
59,20562,08663,48633,94018,59415,630
Upgrade
Cash Income Tax Paid
487,125307,026319,321188,47342,36938,429
Upgrade
Levered Free Cash Flow
106,72555,875-446,65321,97862,86041,358
Upgrade
Unlevered Free Cash Flow
134,20887,161-395,65562,01972,05251,411
Upgrade
Change in Working Capital
506,545-45,375298,743-263,485-234,840-203,535
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.